Shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) rose 11.5% on Thursday . The stock traded as high as $14.00 and last traded at $11.27. Approximately 61,672 shares were traded during trading, a decline of 98% from the average daily volume of 3,664,720 shares. The stock had previously closed at $10.11.
The company has a current ratio of 0.03, a quick ratio of 0.03 and a debt-to-equity ratio of 2.34.
NRx Pharmaceuticals Company Profile (NASDAQ:NRXP)
NRX Pharmaceuticals, Inc, a clinical-stage small molecule pharmaceutical company, develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company's pipeline includes medicinal candidates in Phase 2 and Phase 3 trials for COVID-19-related lung injury and acute respiratory distress.
See Also: Economic Bubble
Receive News & Ratings for NRx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NRx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.